Clinical trials
Completed Hyperlipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
584 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 4 |
| 2002 | 5 |
| 2003 | 10 |
| 2004 | 31 |
| 2005 | 32 |
| 2006 | 27 |
| 2007 | 34 |
| 2008 | 17 |
| 2009 | 24 |
| 2010 | 22 |
| 2011 | 39 |
| 2012 | 29 |
| 2013 | 27 |
| 2014 | 24 |
| 2015 | 29 |
| 2016 | 32 |
| 2017 | 25 |
| 2018 | 25 |
| 2019 | 19 |
| 2020 | 17 |
| 2021 | 19 |
| 2022 | 22 |
| 2023 | 20 |
| 2024 | 15 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 584 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 21 |
| AstraZeneca | 20 |
| Amgen | 17 |
| Takeda | 16 |
| University Health Network, Toronto | 9 |
| Chong Kun Dang Pharmaceutical | 8 |
| Esperion Therapeutics, Inc. | 8 |
| University of Toronto | 8 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 7 |
| Boryung Pharmaceutical Co., Ltd | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 584 |
| Hypertension | 134 |
| Hypercholesterolemia | 99 |
| Diabetes Mellitus | 86 |
| Dyslipidemias | 69 |
| Cardiovascular Diseases | 68 |
| Obesity | 60 |
| Diabetes Mellitus, Type 2 | 32 |
| Metabolic Syndrome | 28 |
| Insulin Resistance | 24 |
Trials
Showing 1 to 25 of 584. Each trial links to its page on Pharma Observatory.
484 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.